AMB HK ENTERPRISES INC. is a privately held pharmaceutical and healthcare company based in the Philippines. The firm primarily engages in the importation, distribution, and commercialization of medicines, medical devices, medical supplies, food supplements, and related healthcare products. It operates as part of the broader AMB-HK Group of Companies, which maintains activities across both human pharmaceutical and veterinary healthcare markets.1

The company’s public-facing brand is AMB-HK, with corporate positioning summarized by the tagline “Your Partner in Total Healthcare.” Its business model combines traditional pharmaceutical importing and distribution with OEM (Original Equipment Manufacturer) and in-house brand development services, allowing clients to develop healthcare products under their own brands.1

Public records from the Philippine Securities and Exchange Commission identify AMB HK ENTERPRISES INC. under SEC registration number CS200911883. 2 The company’s published contact information locates its Manila-area office in Bagong Ilog, Pasig City.1

Note: Discrepancies exist between public sources regarding specific founding dates and employee counts. LinkedIn profiles associated with AMB-HK provide varying data, so exact historical milestones should be treated as company-profile information rather than independently verified facts.34

Material from AMB-HK indicates that the business evolved from a local pharmaceutical distributor into a multi-faceted group covering pharmaceuticals, medical products, food supplements, and veterinary healthcare. An earlier company catalog noted that AMB HK ENTERPRISES INC. had more than 10 years of operating history at the time of publication, citing an expansion of its portfolio and international manufacturer relationships during that period.1

Recent corporate materials describe a structure expanded through specialized subsidiary businesses. A 2025 AMB catalog identifies key entities within the group:

• AMB HK ENTERPRISES INC. — Importation and distribution of generic medicines, medical devices, supplies, and food supplements, including proprietary brands.
• PhilRx Pharma Inc. — Generic medicines, medical devices, and food supplements.
• Nextgen — Branded and innovator medicines from global manufacturers.
• P&D Medivet Distribution Inc. — Poultry and livestock products.
• Pet Prime International Corp. — Veterinary products.
• FSPC — Dermatological, beauty, and cosmetic products.

These entities represent different stages of the group’s development, ranging from veterinary distribution to specialized healthcare. These descriptions reflect AMB-HK’s own corporate history presentation rather than independently audited timelines.

Pharmaceutical Importation and Distribution

The core operation of AMB HK ENTERPRISES INC. is the importation and distribution of pharmaceutical products. The company maintains relationships with manufacturers in China, India, Europe, Vietnam, and Malaysia, aiming to supply quality products at competitive prices for the Philippine market.1

Its portfolio covers a broad range of therapeutic areas, including:
* Cardiovascular medicines
* Anti-infective and oncology products
* Respiratory and anti-allergy medicines
* Central nervous system medicines
* Analgesics and anesthetics
* Gastrointestinal medicines
* Blood-related medicines
* Urology and nephrology products
* Hormonal therapies
* Dermatological products
* Vaccines, biologicals, and monoclonal antibodies
* Liver-related medicines

This breadth positions the company as a generalist pharmaceutical importer/distributor rather than a narrowly specialized manufacturer.

Medical Devices and Supplies

AMB-HK distributes medical devices and supplies as part of its wider healthcare portfolio. The strategy emphasizes a diversified offering encompassing medicines, devices, supplies, nutraceuticals, and veterinary products, positioning the entity as a total-healthcare supplier.1

Food Supplements and Nutraceuticals

Food supplements constitute another segment of the portfolio. The company lists these items among its distributed categories and those available through its OEM service.1

OEM and Private-Label Services

A distinctive aspect of AMB-HK’s operations is its OEM/in-house-branding service. Beyond distributing existing products, the company assists clients in creating healthcare products under client-owned brands. Through its purchasing operations in China, it works with over 30 local and international suppliers, including GMP-accredited manufacturers. Services include coordination of:
* Product formulation/molecule selection
* Packaging
* Brand development
* Documentation
* Regulatory registration
* Importation

This makes the business model partly B2B contract/OEM-oriented alongside conventional distribution.1

AMB-HK collaborates with regional and national distributors within the Philippines to reach pharmacies, hospitals, clinics, and other healthcare providers.1 This intermediary role connects international manufacturers with the domestic healthcare market via a supply chain structured as:

International manufacturers → AMB-HK importation → Philippine distribution network → Pharmacies/Hospitals/Clinics → Patients/Consumers

Published contact information lists offices in:
* Philippines: Pasig City
* China: Tongling City, Anhui Province
* Pakistan: Lahore, Punjab1

The China office functions as a satellite purchasing office supporting relationships with pharmaceutical and healthcare manufacturers.1 Corporate materials also assert an international footprint extending beyond the Philippines.3

AMB-HK appears in Philippine regulatory and procurement records. FDA documents list AMB HK ENTERPRISES INC. as the applicant for various products, including Philsin-8 (silodosin), Levofix (levofloxacin), Cipriza (ciprofloxacin), Glutaphil (semaglutide), and Benzacare (benzathine benzylpenicillin). MIMS Philippines also lists the company as a marketer for products containing dapagliflozin, citicoline, and amino-acid formulations.

In government procurement, a January 21, 2026 notice of award from the Department of Health identified AMB HK ENTERPRISES INC. as the successful bidder for supplying pharmaceutical drugs and contrast media to the Ilocos Training and Regional Medical Center, valued at ₱3,276,183. Other DOH documents also list the company among participating bidders.

Regarding market position, the company claims top rankings among Philippine pharmaceutical importers. A 2025 catalog cites figures such as being the Top 5 importer by sales and Top 1 by volume, working with 50+ GMP-registered foreign manufacturers and 250+ local partners, with 2023 sales revenue reported at $150 million. These are company-published figures.1

AMB-HK identifies five principal values: Integrity, Synergy, Commitment, Excellence, and Innovation.1 Its vision is to become a leading name in the importation and distribution of affordable, high-quality healthcare products.

Socially, the company states commitments to providing healthcare assistance to underserved communities, conducting medical missions, promoting health awareness, ensuring proper pharmaceutical-waste handling, and complying with Department of Environment and Natural Resources standards.1

The entity is best understood as part of the AMB-HK Group:

• AMB HK ENTERPRISES INC.: Pharmaceuticals, medical supplies/devices, food supplements, OEM/private label.
• PhilRx Pharma Inc.: Generic pharmaceutical products.
• Nextgen: Branded and innovator medicines.
• Pet Prime International Corp.: Veterinary products.
• P&D Medivet Distribution Inc.: Animal-health, poultry, and livestock products.
• FSPC: Dermatology, beauty, and cosmetic products.

Exact legal ownership relationships between these entities are not fully documented in public sources, so this structure represents the group’s own presentation.

AMB Building
No. 6 Felipe Pike Street
Bagong Ilog, Pasig City
Metro Manila, Philippines

1. About Us – AMB HK Enterprises Inc.
2. Released Requests for Certificate of No Derogatory
3. AMB HK Enterprises, Inc | LinkedIn
4. AMB HK Enterprises, Inc | LinkedIn